tiprankstipranks
Trending News
More News >
Microbix Biosystms J (TSE:MBX)
TSX:MBX
Canadian Market

Microbix Biosystms (MBX) Earnings Dates, Call Summary & Reports

Compare
35 Followers

Earnings Data

Report Date
Feb 12, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
<0.01
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Dec 18, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted substantial achievements in product development and operational efficiencies, positioning Microbix for future growth. However, the company faced significant revenue declines and profitability challenges in the second half of the year due to unexpected client losses and market conditions in China. Despite these setbacks, the company maintains a strong financial position and a positive outlook for recovery in fiscal 2026.
Company Guidance
In the recent call, Microbix provided guidance that highlighted both challenges and opportunities for fiscal 2025 and the outlook for 2026. The company experienced a 27% decline in revenue, primarily due to a 100% reduction in Kinlytic revenues from $4.1 million in the previous year, as well as a slowdown in sales to China and the cancellation of a multi-hundred-million-dollar program with a major client. Despite these setbacks, other revenue areas increased by 12%. The gross margin decreased from 61% to 53%, attributed largely to the absence of Kinlytic sales. Operational improvements were noted, with batch yields increasing and failures decreasing significantly. For fiscal 2026, Microbix is targeting a 30% revenue growth from the low point of Q3, aiming to regain quarterly profitability by Q4. The company maintained a strong cash position of over $12 million and has access to up to $24 million in additional funds through undrawn credit facilities, ensuring financial resources to execute its plans without issuing new equity.
New Product Launches and Collaborations
Microbix announced several new product lines and collaborations, including the QUANTDx reference materials product line and partnerships with companies like SEKISUI and Seegene. These initiatives are expected to drive future growth and expand addressable markets.
Operational Efficiency Improvements
The company achieved significant improvements in batch yields and reduced failure rates, leading to lower costs and higher margins. Investments in automation and electronic quality management systems are expected to further enhance efficiencies.
Strong Financial Position
Microbix ended the fiscal year with a strong cash balance of over $12 million and access to additional funds through an undrawn mortgage facility and line of credit, totaling up to $24 million.
Support for Industry Needs
The company continued its support for public health with new products for emerging respiratory pandemics and collaborations for cervical cancer screening in multiple countries.

Microbix Biosystms (TSE:MBX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:MBX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 2026
2026 (Q1)
- / -
0.006
Dec 18, 2025
2025 (Q4)
- / -0.01
0.003-466.67% (-0.01)
Aug 14, 2025
2025 (Q3)
- / -0.01
0.002-700.00% (-0.01)
May 15, 2025
2025 (Q2)
- / 0.00
0.003
Feb 13, 2025
2025 (Q1)
- / <0.01
0.018-66.67% (-0.01)
Dec 19, 2024
2024 (Q4)
- / <0.01
0.014-78.57% (-0.01)
Aug 14, 2024
2024 (Q3)
- / <0.01
-0.006133.33% (<+0.01)
May 15, 2024
2024 (Q2)
- / <0.01
0
Feb 14, 2024
2024 (Q1)
- / 0.02
-0.009300.00% (+0.03)
Dec 21, 2023
2023 (Q4)
>-0.01 / 0.01
-0.009255.56% (+0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:MBX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Dec 18, 2025
C$0.24C$0.21-12.50%
Aug 14, 2025
C$0.28C$0.24-14.29%
May 15, 2025
C$0.36C$0.34-5.56%
Feb 13, 2025
C$0.48C$0.480.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Microbix Biosystms J (TSE:MBX) report earnings?
Microbix Biosystms J (TSE:MBX) is schdueled to report earning on Feb 12, 2026, TBA (Confirmed).
    What is Microbix Biosystms J (TSE:MBX) earnings time?
    Microbix Biosystms J (TSE:MBX) earnings time is at Feb 12, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:MBX EPS forecast?
          Currently, no data Available